The future of digital health part 2: Digital patient engagement and virtual healthcare delivery

Part 2

Last week, we started a new series featuring healthcare visionary and thought leader Andy Dé. In this series, Dé discusses how COVID-19 has triggered remarkable digital transformation and uncovers five long-term innovation implications that providers, healthcare leaders, and payers need to consider.

Catch up on the first implication—advanced analytics for vaccine administration—then read on to explore number two in this week’s article.


Innovation implication #2: Digital patient engagement and virtual healthcare delivery

Protecting the health, well-being and safety of healthcare practitioners and first responders is paramount — and will accelerate adoption of Digital Patient Engagement (DPE), enabled by Virtual Healthcare Delivery (VHD) solutions (also known as “Hospital at Home.)”

As pictured below, there are three primary drivers for DPE and VHD:

  1. A clear need to deliver high quality healthcare to a massive number of patients afflicted with a contagious disease and co-morbidities.
  2. Risks presented by acquiring COVID-19 combined with continued lack of sufficient equipment, PPE, and rest for healthcare workers
  3. The need to minimize direct contact of providers with patients while increasing level of care efficiency and productivity

When I have this conversation with healthcare colleagues, the next question I typically receive is: “Andy, this sounds great, but where do we start?” The chart below demonstrates several helpful examples of how technology can be used to transform typical patient interactions and needs:

If you’re interested in more details about how to actually make changes like the ones described above, reach out to start a conversation. Join me back here on the MedeAnalytics blog next week for Innovation implications #3: Artificial intelligence and machine learning for operations, revenue cycle and supply change management innovation and #4: Medical robotics.

Andy Dé

Andy Dé is the Chief Marketing Officer. Andy joined MedeAnalytics in March 2021 bringing more than 20 years of enterprise software product marketing, product management and industry strategy experience. In his role, Andy oversees the company’s go-to-market (GTM) strategy and marketing. He is passionate about healthcare innovation and is recognized as an industry thought leader in healthcare.

Get our take on industry trends

4 tactics to harness data analytics for patient access engagement and efficiency

June 5, 2023

As healthcare consumers and regulatory bodies push for more transparency in medical services and transactions, provider organizations are applying greater…

Read on...

Proactively predicting ER visit trends with augmented analytics to improve revenues, asset utilization and patient outcomes

May 19, 2023

Mission critical emergency departments (EDs) are the most valuable revenue generating asset for hospitals. While visits decreased during the pandemic,…

Read on...

Conversations at HIMSS23

May 5, 2023

HIMSS23 was nothing short of outstanding. I was thrilled to see the familiar faces of colleagues and clients, mingle with…

Read on...
comorbidity photo

Best practice tools to build an integrated approach to multimorbidity

April 10, 2023

The traditional model of treating single diseases no longer works. Data collected from 2016 to 2019 indicated that 32.9% of…

Read on...